As the dust settles on a historic midterm election that saw the Democratic Party secure control of the 120th Congress, the political atmosphere in Washington is charged with a new, defiant energy. While the White House remains firmly in the hands of the Trump administration—which recently took to social media to reiterate that "DEI is still dead"—a contingent of newly elected, science-literate lawmakers is preparing for a legislative showdown.
For the past two years, the federal scientific landscape has been defined by systematic dismantling. From the termination of grants aimed at documenting medical inequities to the chilling of international collaborations and the intense scrutiny of diversity initiatives at medical schools, the scientific community has been reeling. Now, with a legislative mandate to serve as a check on executive power, incoming members of Congress are positioning health equity not as a partisan "woke" project, but as a foundational necessity for public health.
The State of the Scientific Ecosystem: A Two-Year Retrospective
To understand the urgency felt by the incoming cohort of legislators, one must examine the systematic shifts within the National Institutes of Health (NIH) and other federal scientific bodies since 2025.
Chronology of Disruption
- Early 2025: The Trump administration begins a targeted campaign to defund programs aimed at "remedying medical inequities," viewing them as ideological rather than scientific.
- Mid-2025: The administration initiates a series of investigations into prestigious medical schools and universities, alleging that their admissions processes discriminate against white and Asian applicants in the name of diversity.
- Late 2025: New restrictions on "foreign subawards" force major research institutions to halt long-term longitudinal studies, particularly those focused on global health issues like HIV transmission.
- 2026: The implementation of "grant screening," where algorithms flag specific terminology—such as "disproportionate," "Black," or "gender"—leads to a chilling effect on academic research. The resulting controversy triggers a First Amendment lawsuit against the NIH.
Throughout this period, the administration has successfully wielded its executive power to reshape the priorities of federal science, often bypassing traditional peer-review processes in favor of ideological vetting.
The New Legislative Guard: Science Credentials in the Halls of Power
Among the most significant developments in the 120th Congress is the arrival of individuals who possess both the political mandate and the technical expertise to challenge these policies. Two figures, in particular, have emerged as the vanguard of this effort.
Senator-elect Abdul El-Sayed: The Epidemiologist’s Perspective
Dr. Abdul El-Sayed, an epidemiologist and former health disparities researcher, arrives in the Senate with a clear agenda. His background in studying maternal health and the unique disparities within the Arab American community provides him with a granular understanding of what is at stake when data collection is suppressed.
"The war on diversity, equity, and inclusion is about a vision of an America that doesn’t include certain kinds of people," El-Sayed remarked in an interview. For El-Sayed, the suppression of data isn’t just a matter of academic freedom; it is a public health failure. "We need to be able to document the ways in which our systems are allowing for and, in some respects, creating the differences in the ability for people to live long, healthy lives. It’s important work, and it should help guide where public policy gaps are."
Rep. Jasmine Clark: A Microbiologist in the Trenches
Rep.-elect Jasmine Clark, a microbiologist, is set to become the first Black woman with a STEM Ph.D. to serve in Congress. Her experience in academia informs her skepticism of the current administration’s "war on DEI."
"I know firsthand what DEI initiatives can do for students who are trying to find their way," Clark told STAT. Her concerns go beyond the classroom; she is deeply alarmed by the impact of current policies on laboratory output. Specifically, she points to the disruption of HIV transmission studies in Africa, noting that the bureaucratic hurdles imposed by the administration have created "holes in our data" that may take years to mend.
Bridging the Ideological Divide: What the Data Says
While the term "DEI" has been effectively weaponized in political discourse, the actual policy goals—often categorized under "health equity"—maintain broad support among the American public.
Philip Alberti, director of the Association of American Medical Colleges (AAMC) Center for Health Justice, argues that the current political framing is a distortion of reality. Data from the AAMC suggests that roughly 75% of U.S. adults support the goal of ensuring that all communities have a fair and just opportunity to be healthy.
"This is not controversial," Alberti noted. "When you remove the buzzwords and focus on the outcome—a fair chance at health—the support is universal across ideological lines." This disparity between political rhetoric and public sentiment provides a strategic opening for lawmakers like Clark and El-Sayed. They intend to reframe the debate, moving away from identity-based attacks and toward the tangible benefits of inclusive, data-driven research.
Implications for Oversight and Accountability
With Democrats controlling both chambers of the 120th Congress, the era of executive autonomy for the Trump administration’s health appointees may be coming to an end.
The Kennedy Question
A primary target for the new Congress is the Department of Health and Human Services, specifically the leadership of Robert F. Kennedy Jr. Legislators are preparing to use their committee assignments to demand answers regarding:
- Grant Terminations: Who was harmed by the cancellation of specific health equity research projects?
- International Collaboration: Why were restrictions placed on global health data, and what is the cost to national security and global pandemic readiness?
- The Guinea-Bissau Study: Rep. Clark has indicated a desire to investigate the administration’s promotion of a controversial hepatitis B vaccine study in Guinea-Bissau, comparing its ethical implications to historical injustices like the Tuskegee syphilis experiment.
The Power of the Purse
While the President retains veto power, the Congressional "power of the purse" remains a formidable tool. Legislators are expected to introduce language in appropriations bills that explicitly protects funding for research that examines disparities. This sets up a potential budget showdown, as the administration will be forced to decide whether to veto essential government funding bills to maintain its stance against "woke" science.
Conclusion: A Path Toward Restoration
The road ahead is undoubtedly difficult. With a veto-wielding President and a polarized political environment, the Democratic majority will struggle to pass transformative legislation. However, the presence of scientists like El-Sayed and Clark changes the tenor of the debate.
By demanding transparency, asserting the necessity of data-driven policy, and connecting the abstract concept of "DEI" to the concrete reality of life-saving research, these lawmakers are attempting to move the needle. They argue that the future of American science depends on a system that is transparent, inclusive, and committed to addressing the health disparities that continue to plague the nation.
As the 120th Congress begins its session, the "war on science" is entering a new, more confrontational phase. Whether this legislative pushback can effectively reverse the damage of the last two years remains to be seen, but for the scientific community, the prospect of having allies on Capitol Hill is a significant, and perhaps necessary, step toward restoration.
